P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease ; volume:8 ; number:1 ; day:10 ; month:8 ; year:2020 ; pages:1-21 ; date:12.2020
Acta Neuropathologica Communications ; 8, Heft 1 (10.8.2020), 1-21, 12.2020
- Urheber
-
Farmer, Kathleen M.
Ghag, Gaurav
Puangmalai, Nicha
Montalbano, Mauro
Bhatt, Nemil
Kayed, Rakez
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-01012-6
- URN
-
urn:nbn:de:101:1-2020100422285648718457
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Farmer, Kathleen M.
- Ghag, Gaurav
- Puangmalai, Nicha
- Montalbano, Mauro
- Bhatt, Nemil
- Kayed, Rakez
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
Emotional prosody recognition is impaired in Alzheimer’s disease
The UFMylation pathway is impaired in Alzheimer’s disease
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer’s disease mouse model
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit